These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 23632095)

  • 1. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.
    Shindoh J; Vauthey JN; Zimmitti G; Curley SA; Huang SY; Mahvash A; Gupta S; Wallace MJ; Aloia TA
    J Am Coll Surg; 2013 Jul; 217(1):126-33; discussion 133-4. PubMed ID: 23632095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.
    Zhang GQ; Zhang ZW; Lau WY; Chen XP
    Int J Surg; 2014; 12(5):437-41. PubMed ID: 24704086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
    Tschuor Ch; Croome KP; Sergeant G; Cano V; Schadde E; Ardiles V; Slankamenac K; Clariá RS; de Santibaňes E; Hernandez-Alejandro R; Clavien PA
    Eur J Surg Oncol; 2013 Nov; 39(11):1230-5. PubMed ID: 23994139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta-analysis of the outcomes of associating liver partition and portal vein ligation for staged hepatectomy versus portal vein embolization for the treatment of liver cancer with insufficient future liver remnant].
    Cao YL; Wang GJ; Li W
    Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):540-548. PubMed ID: 31269618
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis.
    Gavriilidis P; Marangoni G; Ahmad J; Azoulay D
    Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):221-227. PubMed ID: 36100542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.
    Truant S; Scatton O; Dokmak S; Regimbeau JM; Lucidi V; Laurent A; Gauzolino R; Castro Benitez C; Pequignot A; Donckier V; Lim C; Blanleuil ML; Brustia R; Le Treut YP; Soubrane O; Azoulay D; Farges O; Adam R; Pruvot FR;
    Eur J Surg Oncol; 2015 May; 41(5):674-82. PubMed ID: 25630689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological Simultaneous Portohepatic Vein Embolization (RASPE) Before Major Hepatectomy: A Better Way to Optimize Liver Hypertrophy Compared to Portal Vein Embolization.
    Laurent C; Fernandez B; Marichez A; Adam JP; Papadopoulos P; Lapuyade B; Chiche L
    Ann Surg; 2020 Aug; 272(2):199-205. PubMed ID: 32675481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.
    Broering DC; Hillert C; Krupski G; Fischer L; Mueller L; Achilles EG; Schulte am Esch J; Rogiers X
    J Gastrointest Surg; 2002; 6(6):905-13; discussion 913. PubMed ID: 12504230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization.
    Matsuo K; Murakami T; Kawaguchi D; Hiroshima Y; Koda K; Yamazaki K; Ishida Y; Tanaka K
    Surgery; 2016 May; 159(5):1289-98. PubMed ID: 26775576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical modifications and outcomes after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for primary liver malignancies: A systematic review.
    Baili E; Tsilimigras DI; Moris D; Sahara K; Pawlik TM
    Surg Oncol; 2020 Jun; 33():70-80. PubMed ID: 32561102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma: A Changing Paradigm in Modulation of Future Liver Remnant Before Major Hepatectomy.
    Chan A; Zhang WY; Chok K; Dai J; Ji R; Kwan C; Man N; Poon R; Lo CM
    Ann Surg; 2021 May; 273(5):957-965. PubMed ID: 31305284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Percutaneous Intrahepatic Split by Microwave Ablation (PISA) After Portal Vein Embolization for Hypertrophy of Future Liver Remnant: The Radiological Stage-1 ALPPS.
    Lunardi A; Cervelli R; Volterrani D; Vitali S; Lombardo C; Lorenzoni G; Crocetti L; Bargellini I; Campani D; Pollina LE; Cioni R; Caramella D; Boggi U
    Cardiovasc Intervent Radiol; 2018 May; 41(5):789-798. PubMed ID: 29359240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis.
    Yi F; Zhang W; Feng L
    World J Surg Oncol; 2022 Dec; 20(1):399. PubMed ID: 36527081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.
    Deshayes E; Piron L; Bouvier A; Lapuyade B; Lermite E; Vervueren L; Laurent C; Pinaquy JB; Chevallier P; Dohan A; Rode A; Sengel C; Guillot C; Quenet F; Guiu B
    BMC Cancer; 2020 Jun; 20(1):574. PubMed ID: 32560632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
    Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
    Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater hypertrophy can be achieved with associating liver partition with portal vein ligation for staged hepatectomy compared to conventional staged hepatectomy, but with a higher price to pay?
    Chia DKA; Yeo Z; Loh SEK; Iyer SG; Bonney GK; Madhavan K; Kow AWC
    Am J Surg; 2018 Jan; 215(1):131-137. PubMed ID: 28859921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection.
    Lehwald-Tywuschik N; Vaghiri S; Schulte Am Esch J; Alaghmand S; Klosterkemper Y; Schimmöller L; Lachenmayer A; Ashmawy H; Krieg A; Topp SA; Rehders A; Knoefel WT
    BMC Surg; 2020 Apr; 20(1):63. PubMed ID: 32252737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.
    Schadde E; Ardiles V; Slankamenac K; Tschuor C; Sergeant G; Amacker N; Baumgart J; Croome K; Hernandez-Alejandro R; Lang H; de Santibaňes E; Clavien PA
    World J Surg; 2014 Jun; 38(6):1510-9. PubMed ID: 24748319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating surgeon attitudes towards the safety and efficacy of portal vein occlusion and associating liver partition and portal vein ligation: a report of the MALINSA survey.
    Day RW; Conrad C; Vauthey JN; Aloia TA
    HPB (Oxford); 2015 Oct; 17(10):936-41. PubMed ID: 26255813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No difference in mortality among ALPPS, two-staged hepatectomy, and portal vein embolization/ligation: A systematic review by updated traditional and network meta-analyses.
    Gavriilidis P; Sutcliffe RP; Roberts KJ; Pai M; Spalding D; Habib N; Jiao LR; Sodergren MH
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):411-419. PubMed ID: 32753333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.